← Evidence map

ArticleDiabetes2021

Erratum. SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans. Diabetes 2021;70:2364-2376.

Harunobu Nishizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Erratum. SCO-267, a GPR40 Full Agonist, Stimulates Islet and Gut Hormone Secretion and Improves Glycemic Control in Humans. Diabetes 2021;70:2364-2376. | OpenQuestion